Kraig Biocraft Laboratories, Inc. Balance Sheet
KBLB|8 years of annual SEC 10-K data (FY2012-FY2019)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 8 fiscal years. All figures from audited SEC 10-K filings.
Kraig Biocraft Laboratories, Inc. had $750,850 in total assets with negative shareholders' equity of $5M as of FY2019.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -50.01 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | - | $13.7K | $18.1K | $298.9K | $238.2K | $495.0K | $295.4K | $53.8K |
| Accounts Receivable | - | - | $25.9K | $31.9K | $0 | - | - | - |
| Current Assets | $156.8K | $20.6K | $48.5K | $331.8K | $238.8K | $496.0K | $297.1K | $62.2K |
| PP&E (Net) | $117.3K | $47.3K | $62.5K | $51.6K | $66.1K | $43.2K | $14.1K | $16.5K |
| Total Assets | $750.9K | $71.4K | $114.5K | $383.7K | $304.9K | $539.2K | $311.2K | $78.8K |
| Current Liabilities | $5.6M | $4.5M | $3.5M | $2.7M | $2.2M | $1.8M | $1.5M | $1.2M |
| Total Debt | - | - | - | - | - | - | - | $8.8K |
| Shareholders' Equity | -$5.4M | -$4.5M | -$3.4M | -$2.4M | -$1.9M | -$1.2M | -$1.2M | -$1.1M |